Skip to content
10-Q

Quarterly Report

ABIOMED INC

0001564590-22-003810

← back to feed
Filed
Feb 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Jan 27, 2022 45.52M sh
Shares Diluted Q3 2022 · Dec 31, 2021 45.92M sh
Shares Diluted Q3 2022 · Dec 31, 2021 45.85M sh
Shares Diluted Q3 2022 · Dec 31, 2020 45.71M sh
Shares Diluted Q3 2022 · Dec 31, 2020 45.65M sh
Capex Q3 2022 · Dec 31, 2021 $20.87M
Capex Q3 2022 · Dec 31, 2020 $27.27M
Operating Cash Flow Q3 2022 · Dec 31, 2021 $206.42M
Operating Cash Flow Q3 2022 · Dec 31, 2020 $188.1M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $144.26M
Cash And Equivalents Q3 2022 · Mar 31, 2021 $232.71M
Stockholders Equity Q3 2022 · Dec 31, 2021 $1.43B
Stockholders Equity Q3 2022 · Sep 30, 2021 $1.38B
Stockholders Equity Q3 2022 · Jun 30, 2021 $1.31B
Stockholders Equity Q3 2022 · Mar 31, 2021 $1.33B
Stockholders Equity Q3 2022 · Dec 31, 2020 $1.26B
Stockholders Equity Q3 2022 · Sep 30, 2020 $1.18B
Stockholders Equity Q3 2022 · Jun 30, 2020 $1.1B
Stockholders Equity Q3 2022 · Mar 31, 2020 $1.07B
Current Liabilities Q3 2022 · Dec 31, 2021 $126.8M
Current Liabilities Q3 2022 · Mar 31, 2021 $128.97M
Total Liabilities Q3 2022 · Dec 31, 2021 $159.94M
Total Liabilities Q3 2022 · Mar 31, 2021 $164.68M
Current Assets Q3 2022 · Dec 31, 2021 $885.01M
Current Assets Q3 2022 · Mar 31, 2021 $787.97M
Total Assets Q3 2022 · Dec 31, 2021 $1.59B
Total Assets Q3 2022 · Mar 31, 2021 $1.49B
Eps Diluted Q3 2022 · Dec 31, 2021 $1.00
Eps Diluted Q3 2022 · Dec 31, 2021 $1.66
Eps Diluted Q3 2022 · Dec 31, 2020 $1.35
Eps Diluted Q3 2022 · Dec 31, 2020 $3.69
Eps Basic Q3 2022 · Dec 31, 2021 $1.01
Eps Basic Q3 2022 · Dec 31, 2021 $1.68
Eps Basic Q3 2022 · Dec 31, 2020 $1.37
Eps Basic Q3 2022 · Dec 31, 2020 $3.74
Sga Expense Q3 2022 · Dec 31, 2021 $107.62M
Sga Expense Q3 2022 · Dec 31, 2021 $313.88M
Sga Expense Q3 2022 · Dec 31, 2020 $86.2M
Sga Expense Q3 2022 · Dec 31, 2020 $233.81M
Rd Expense Q3 2022 · Dec 31, 2021 $40.87M
Rd Expense Q3 2022 · Dec 31, 2021 $119.62M
Rd Expense Q3 2022 · Dec 31, 2020 $33M
Rd Expense Q3 2022 · Dec 31, 2020 $89.89M
Net Income Q3 2022 · Dec 31, 2021 $45.75M
Net Income Q3 2022 · Dec 31, 2021 $76.18M
Net Income Q3 2022 · Sep 30, 2021 $56.95M
Net Income Q3 2022 · Jun 30, 2021 −$26.53M
Net Income Q3 2022 · Dec 31, 2020 $61.87M
Net Income Q3 2022 · Dec 31, 2020 $168.67M
Net Income Q3 2022 · Sep 30, 2020 $62.21M
Net Income Q3 2022 · Jun 30, 2020 $44.59M
Operating Income Q3 2022 · Dec 31, 2021 $64.57M
Operating Income Q3 2022 · Dec 31, 2021 $75.72M
Operating Income Q3 2022 · Dec 31, 2020 $71.35M
Operating Income Q3 2022 · Dec 31, 2020 $166.75M
Revenue Q3 2022 · Dec 31, 2021 $261.18M
Revenue Q3 2022 · Dec 31, 2021 $761.9M
Revenue Q3 2022 · Dec 31, 2020 $231.66M
Revenue Q3 2022 · Dec 31, 2020 $606.28M
Stock Repurchased Q3 2022 · Dec 31, 2020 $11.31M